Divi's Laboratories Ltd. Conference Calls and Earnings Call Transcripts

Divi's Laboratories Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
5689.50
-3.52%
5689.50
-3.52%
Conference Call with Divi's Laboratories Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.
5689.50
-3.52%
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Further to our intimation letter dated October 28, 2022, we hereby inform that the audio recording of the earnings conference call for the quarter and half year ended September 30, 2022, held on November 07, 2022 at 14.00 Hrs IST has been uploaded on the Company's website at the following weblink: https://www.divislabs.com/wp-content/uploads/2022/11/Earnings-Call-Audio-Q2FY23_07.11.2022.mp3
5689.50
-3.52%
5689.50
-3.52%
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and further to our intimation letter dated July 29, 2022, we hereby inform that the audio recording of the earnings call for the quarter ended June 30, 2022, held on August 12, 2022 at 14.00 Hrs IST have been uploaded on the Company's website at the following weblink: https://www.divislabs.com/wp-content/uploads/2022/08/EarningsCallAudioQ1FY23.mp3 This is for your information and records.
logo
Divi's Laboratories Ltd.
26 May 2022, 12:21PM
5689.50
-3.52%
5689.50
-3.52%
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and further to our intimation letter dated May 16, 2022, we hereby inform that the audio recording of the earnings call for the quarter and financial year ended March 31, 2022, held on May 23, 2022, at 14.00 Hrs IST have been uploaded on our website at the following weblink: https://www.divislabs.com/wp-content/uploads/2022/05/DIV0320220523141281.mp3 This is for your information and records.
5689.50
-3.52%
Conference Call with Divi's Laboratories Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.
5689.50
-3.52%
Conference Call with Divi's Laboratories Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
5689.50
-3.52%
Conference Call with Divi's Laboratories Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.

Earnings Calls Podcast on